一、基本信息
汪棋，1997年1月，男，汉族，江西九江，博士，校聘教授。主要从事畜禽肠道共生微生物组与精准营养相关研究。
二、科研项目概况
先后主持国家自然科学基金1项，江苏省自然科学基金1项，作为学术骨干参与国家级科研项目2项，累计发表学术论文12篇，其中第一/通讯作者在Journal of Agricultural and Food Chemistry，International Journal of Biological Macromolecules等SCI刊物发表论文10篇。
三、教育经历（按时间倒序）
2024.06‑2026.09：中国人民解放军东部战区总医院，助理研究员
2019.09-2024.06：浙江大学，动物科学学院，动物营养饲料科学专业，博士
2015.09-2019.06：华南农业大学，动物科学学院，动物科学专业，本科
四、工作经历（按时间倒序）
2024.06‑2026.09：中国人民解放军东部战区总医院，助理研究员
五、代表性研究成果和学术奖励情况
（一）代表性 SCI 学术论文（近五年优先，按时间降序）
1.Wang, Q.; Jin, Q.; Wang, F.; Wang, Y.; Li, X.; Zhou, Y.; Xu, S.; Fu, A.; Li, W., Bacillus amyloliquefaciens SC06 alleviates LPS-induced intestinal damage by inhibiting endoplasmic reticulum stress and mitochondrial dysfunction in piglets. International Journal of Biological Macromolecules, 2024, 282. (中科院一区,IF5year = 8.2).
2.Qi Wang, Fei Wang, Li Tang, Yang Wang, YuanHao Zhou, Shujie Xu, Xiang Li, Qian Jin, Weifen Li*. Bacillus amyloliquefaciens SC06 relieving intestinal inflammation by modulating Intestinal Stem cells proliferation and differentiation via AhR/STAT3 Pathway in LPS-challenged piglets. Journal of Agricultural and Food Chemistry. 2024, 10(1021), 3c05956. (中科院一区, IF5year = 6.3)
3.Qi Wang, Fei Wang, Li Tang, Yang Wang, YuanHao Zhou, Shujie Xu, Xiang Li, Qian Jin, Weifen Li*. Bacillus amyloliquefaciens SC06 Attenuated Lipopolysaccharide-Induced Acute Liver Injury by suppressing bile acid-associated NLRP3 inflammasome activation. International Immunopharmacology. 2024, 142. (中科院二区TOP, IF5year = 5.6).
4.Qi Wang, Xiaoli Zhan, Baikui Wang, Fei Wang, YuanHao Zhou, Shujie Xu, Xiang Li, Li Tang, Qian Jin, Weifen Li, Li Gong*, Aikun Fu*. Modified Montmorillonite Improved Growth Performance of Broilers by Modulating Intestinal Microbiota and Enhancing Intestinal Barriers, Anti-Inflammatory Response, and Antioxidative Capacity[J]. Antioxidants, 2022, 11(9), 1799. (中科院一区2022, IF5year = 7.3)
5.Qi Wang, Fei Wang, Li Tang, Yang Wang, Yuanhao Zhou, Xiang Li, Mingliang Jin, Aikun Fu*, Weifen Li*. Bacillus amyloliquefaciens SC06 alleviated intestinal damage induced by inflammatory via modulating intestinal microbiota and intestinal stem cell proliferation and differentiation. International Immunopharmacology. 130, 111675. (中科院二区TOP, IF5year = 5.6)
6.Qi Wang, Jiafu Ying, Peng Zou, Peng Zou, Baikui Wang, Dongyou Yu, Weifen Li, Xiaoli Zhan*. Effects of Dietary Supplementation of Humic Acid Sodium and Zinc Oxide on Growth Performance, Immune Status and Antioxidant Capacity of Weaned Piglets. Animals, 2020, 10(11), 2104. (JCR1区,IF5year = 3.3)
7.Wu, M., Wang, Q., Li, X., Yu, S., Zhao, F., Wu, X., Fan, L., Liu, X., Zhao, Q., He, X., Li, W., Zhang, Q., & Hu, X. (2024). Gut microbiota-derived 5-hydroxyindoleacetic acid from pumpkin polysaccharides supplementation alleviates colitis via MAPKs-PPARgamma/NF-kappaB inhibition. International Journal of Biological Macromolecules, 130385. (共同一作，中科院一区, IF5year = 8.2)
8.Deng, H. B.; Cheng, S.; Fan, J. M.; Hao, H. B.; Fang, D. D.; Li, W. Q.; Wang, Q., Bacillus amyloliquefaciens SC06 Ameliorated Intestinal Mucosal Injury by Regulated Intestinal Stem Cells Proliferation and Differentiation via Activating Wnt/β-Catenin Signal Pathway in Clostridium perfringens-Challenged Mouse. Microorganisms, 2025, 13 (9). (第一通讯作者，中科院二区, IF = 4.2).
9.Hou G.; Deng H.; Zhou L.; Liu Y.; Li W.; Li W.; Wang Q., Lactobacillus rhamnosus GG Alleviates Post-Weaning Stress-Induced Intestinal Barrier Damage and Inflammation by Promoting Intestinal Health and Modulating the Gut Microbiota in Piglets. Microorganisms, 2026, 14 (2). (主要通讯作者，中科院二区, IF = 4.2).
10.Li K.; Hou G.; Deng H.; Lu W.; Liu H.; Li W.; Tong Z, Wang Q;, Hesperidin alleviated D-GalN/LPS induced acute liver injury in mice: insights into gut microbiota and the Nrf2/Keap1 pathway. Front Microbiol, 2025, 16, 1725863. (主要通讯作者，中科院二区, IF = 5.4).
11.Lu W. T.; Liu Y.; Hao H. B.; Li X.; Hou G. H.; Zhang J. X.; Li W. F.; Huang Q; Wang Q., Lacticaseibacillus paracasei 18 effectively ameliorates dextran sodium sulfate-induced colitis in mice through regulating gut microbiota metabolitemediated PI3K/AKT/NF-κB signaling pathway. International Immunopharmacology, 2026, 182. (主要通讯作者，中科院二区, IF = 4.2)
（二）发明专利
无
（三）学术奖励情况
无
六、主持或参加科研项目及人才计划项目情况（时间倒序）
格式：项目名称（项目类型），项目编号，起止年月，角色（主持人 / 参与人），是否结题。
1.国家自然科学基金青年C类项目，副干酪乳杆菌LP43激活IL-22/STAT3信号轴促进重症急性胰腺炎肠黏膜损伤修复的机制研究，主持，82604318, 2027.01-2029.12，30.00万元，在研。
2.江苏省自然科学基金青年项目，基于肠道干细胞增殖分化副干酪乳杆菌缓解重症急性胰腺炎肠功能障碍的机制研究，主持，BK20251677，2025.12-2027.12，20.00 万元，在研。
3.东部战区总医院院内课题，益生菌通过调节肠道干细胞增殖分化缓解胰腺炎继发肠屏障功能障碍，96601，主持，30.00万元，在研。
七、其他
